Agios Pharmaceuticals Inc Sustainability Reports

Agios Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing therapies for genetically defined diseases, with a primary concentration on rare diseases and hemolytic anemias.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 529900ONJHY8EOGYT555

FIGI: BBG001T8R687

10 reports from 2016 to 2025

• Agios Pharmaceuticals Inc 2025 Environmental, Social, and Governance Report
• Agios Pharmaceuticals Inc 2024 Environmental, Social, and Governance Report
• Agios Pharmaceuticals Inc 2023 Environmental, Social and Governance Report
• Agios Pharmaceuticals Inc 2022 Environmental, Social and Governance Report
• Agios Pharmaceuticals Inc 2022 Annual Report